Skip to main content
OpenTrials

Clinical trial condition

Hodgkin Disease

Explore clinical trials studying Hodgkin Disease. Study availability and eligibility vary by location and protocol.

958 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Hodgkin Disease trial results

Completed

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

NCT00285259

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +37 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of South Florida Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin

NCT04998331

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • Hospital General Vega Baja San Bartolomé, Alicante, Spain
  • Hospital Universitario de Alava Vitoria-Gasteiz, Araba, Spain
  • Ico Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Galdakao Galdakao, Bizkaia, Spain
View all 30 locations
View Trial Details
Completed

Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas

NCT01793233

Conditions
Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +21 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 107 locations
View Trial Details
Completed

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

NCT02576496

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Cutaneous T Cell Lymphoma, +23 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Cancer Center Jacksonville, Florida, United States
  • Columbia University Medical Center New York, United States
  • University Hospitals Cleveland Seidman Cancer Center Cleveland, Ohio, United States
View all 18 locations
View Trial Details
Completed

A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation

NCT03942263

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • State budgetary healthcare institution of the Astrakhan region Alexander-Mariinsky regional clinical hospital Astrakhan, Russia
  • Autonomous Institution "Republican Clinical Oncology Dispensary" of the Ministry of Health of Chuvashia Cheboksary, Russia
  • State budgetary health care institution "Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine" Chelyabinsk, Russia
  • State Budget Public Health Institution "Regional Oncological Dispensary" Irkutsk, Russia
View all 50 locations
View Trial Details
Completed

A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)

NCT01716806

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of South Alabama - Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Urological Institute Anchorage, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
View all 54 locations
View Trial Details
Completed

Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma

NCT01492088

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations
  • Aurora, Colorado, United States
  • Kansas City, Missouri, United States
  • New York, United States
  • Houston, Texas, United States
View all 18 locations
View Trial Details

Related conditions